Pinnacle Financial Partners (Georgia)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Pinnacle Financial Partners (Georgia)'s NVO Position: Q2 2026 in Review
Pinnacle Financial Partners (Georgia) reduced its Novo Nordisk (NVO) stake by 0.4% in Q2 2026, selling an estimated $6.06K and leaving 34,932 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #530.
Pinnacle Financial Partners (Georgia) first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Pinnacle Financial Partners (Georgia) held 34,932 shares of Novo Nordisk worth $1.67M as of Q2 2026.
- Pinnacle Financial Partners (Georgia) sold 141 Novo Nordisk shares in Q2 2026, an estimated $6.06K.
- Novo Nordisk made up 0.01% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #530 holding.
- Pinnacle Financial Partners (Georgia) first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.